A new class of HIV-1 protease inhibitors containing a tertiary alcohol in the transition-state mimicking scaffold

被引:40
作者
Ekegren, JK
Unge, T
Safa, MZ
Wallberg, H
Samuelsson, B
Hallberg, A
机构
[1] Uppsala Univ, BMC, Dept Med Chem Organ Pharmaceut Chem, SE-75123 Uppsala, Sweden
[2] Uppsala Univ, BMC, Dept Cell & Mol Biol Struct Biol, SE-75124 Uppsala, Sweden
[3] Medivir AB, SE-14144 Huddinge, Sweden
关键词
D O I
10.1021/jm050790t
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Novel HIV-1 protease inhibitors encompassing a tertiary alcohol as part of the transition-state mimicking unit have been synthesized. Variation of the P-1'-P-3' residues and alteration of the tertiary alcohol absolute stereochemistry afforded 10 inhibitors. High potencies for the compounds with (S)-configuration at the carbon carrying the tertiary hydroxyl group were achieved with K-i values down to 2.4 nM. X-ray crystallographic data for a representative compound in complex with HIV-1 protease are presented.
引用
收藏
页码:8098 / 8102
页数:5
相关论文
共 39 条
  • [1] HIV protease inhibitors: Peptidomimetic drugs and future perspectives
    Abdel-Rahman, HM
    Al-karamany, GS
    El-Koussi, NA
    Youssef, AF
    Kiso, Y
    [J]. CURRENT MEDICINAL CHEMISTRY, 2002, 9 (21) : 1905 - 1922
  • [2] INHIBITION OF CATHEPSIN-D BY SUBSTRATE-ANALOGS CONTAINING STATINE AND BY ANALOGS OF PEPSTATIN
    AGARWAL, NS
    RICH, DH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1986, 29 (12) : 2519 - 2524
  • [3] Design and synthesis of new potent C2-symmetric HIV-1 protease inhibitors.: Use of L-mannaric acid as a peptidomimetic scaffold
    Alterman, M
    Björsne, M
    Mühlman, A
    Classon, B
    Kvarnström, I
    Danielson, H
    Markgren, PO
    Nillroth, U
    Unge, T
    Hallberg, A
    Samuelsson, B
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (20) : 3782 - 3792
  • [4] Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK1 receptor antagonist
    Ashwood, VA
    Field, MJ
    Horwell, DC
    Julien-Larose, C
    Lewthwaite, RA
    McCleary, S
    Pritchard, MC
    Raphy, J
    Singh, L
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (14) : 2276 - 2285
  • [5] HIGHLY DIASTEREOSELECTIVE REACTION OF A CHIRAL, NON-RACEMIC AMIDE ENOLATE WITH (S)-GLYCIDYL TOSYLATE - SYNTHESIS OF THE ORALLY-ACTIVE HIV-1 PROTEASE INHIBITOR L-735,524
    ASKIN, D
    ENG, KK
    ROSSEN, K
    PURICK, RM
    WELLS, KM
    VOLANTE, RP
    REIDER, PJ
    [J]. TETRAHEDRON LETTERS, 1994, 35 (05) : 673 - 676
  • [6] BALANI SK, 1995, DRUG METAB DISPOS, V23, P266
  • [7] ISOLATION OF A T-LYMPHOTROPIC RETROVIRUS FROM A PATIENT AT RISK FOR ACQUIRED IMMUNE-DEFICIENCY SYNDROME (AIDS)
    BARRESINOUSSI, F
    CHERMANN, JC
    REY, F
    NUGEYRE, MT
    CHAMARET, S
    GRUEST, J
    DAUGUET, C
    AXLERBLIN, C
    VEZINETBRUN, F
    ROUZIOUX, C
    ROZENBAUM, W
    MONTAGNIER, L
    [J]. SCIENCE, 1983, 220 (4599) : 868 - 871
  • [8] New aza-dipeptide analogues as potent and orally absorbed HIV-1 protease inhibitors:: Candidates for clinical development
    Bold, G
    Fässler, A
    Capraro, HG
    Cozens, R
    Klimkait, T
    Lazdins, J
    Mestan, J
    Poncioni, B
    Rösel, J
    Stover, D
    Tintelnot-Blomley, M
    Acemoglu, F
    Beck, W
    Boss, E
    Eschbach, M
    Hürlimann, T
    Masso, E
    Roussel, S
    Ucci-Stoll, K
    Wyss, D
    Lang, R
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (18) : 3387 - 3401
  • [9] Designing non-peptide peptidomimetics in the 21st century: Inhibitors targeting conformational ensembles
    Bursavich, MG
    Rich, DH
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (03) : 541 - 558
  • [10] TI(O-I-PR)4-MEDIATED NUCLEOPHILIC OPENINGS OF 2,3-EPOXY ALCOHOLS - A MILD PROCEDURE FOR REGIOSELECTIVE RING-OPENING
    CARON, M
    SHARPLESS, KB
    [J]. JOURNAL OF ORGANIC CHEMISTRY, 1985, 50 (09) : 1557 - 1560